Skip to main content
SpringerLink
Log in

Electrophysiologic effects of intravenous xamoterol in patients with sinus node dysfunction

  • Arrhythmias
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Summary

The electrophysiologic effects of xamoterol were studied in ten patients with electrophysiologic evidence of sinus node dysfunction. A significant shortening of mean sinus cycle length, maximal corrected sinus-node recovery time, and the mean of the three longest corrected sinus-node recovery times was observed after intravenous administration of 0.1 mg/kg of xamoterol. The atrioventricular (AV) conduction time and the effective and functional refractory periods of the AV node were shortened as the effective refractory period of the atrium. These effects suggest that xamoterol could be tried safely for the treatment of patients with moderate symptoms due to sinus-node disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Conde CA, Leppo J, Lipski J, et al. Effectiveness of pacemaker treatment in the bradycardia-tachycardia syndrome. Am J Cardiol 1973;32:209.

    PubMed  Google Scholar 

  2. Furman S. Cardiac pacing and pacemakers. Indications for pacing brady-arrhythmias.Am Heart J 1977;93:523

    PubMed  Google Scholar 

  3. Rasmussen K. chronic sinus node disease: Natural course and indications for pacing.Eur Heart J 1981;2:455.

    PubMed  Google Scholar 

  4. Strauss H, Gilbert M, Svenson R, et al. Electrophysiologic effects of propranolol on sinus node function in patients with sinus node dysfunction.Circulation 1976;54:452.

    PubMed  Google Scholar 

  5. Narula O, Vasquez M, Shantha N et al. Effect of propranolol on normal and abnormal sinus node function. In: Bonke F, ed.The sinus node. Dordrecht: Martinus Nijhoff, 1978:112.

    Google Scholar 

  6. Wit A, Hoffman B, Rosen M. Electrophysiology and pharmacology of cardiac arrhythmias in cardiac electrophysiologic effects of β-adrenergic, receptor stimulation and blockade.Am Heart J 1975.;90:795.

    PubMed  Google Scholar 

  7. Hombach V, Braun V, Hopp H, et al. Electrophysiological effects of cardioselective and non-cardioselective betaadrenoceptor blockers with and without ISA at rest and during exercise.Br J Clin Pharmacol 1982;13:285S.

    Google Scholar 

  8. Bittinger S, Smith S, Beta-adrenoceptor, antagonists increase sinus arrhythmia, a vagotonic effect.Br J Clin Pharmacol 1986;22:691.

    PubMed  Google Scholar 

  9. Fitcha P, Tiso B, Meisner W, et al. The effect of sympathomimetic activity of beta-adreno-receptor blockers on circadian heart rate.Br J Clin Pharmacol 1982;13:211S.

    Google Scholar 

  10. Leclercq J, Rosengarten M, Kural S, et al. Effects of intrinsic sympathetic activity of beta blockers on SA and AV nodes in man.Eur J Cardiol 1981;12:367.

    PubMed  Google Scholar 

  11. de Marneffe M, Ewalenko M, Englert M. Treatment of chronic atrial fibrillation: A comparison between digitalis alone and a combination of digitalis and beta-blocking agents.Neu Trends in Arrhythmias 1985;I:91.

    Google Scholar 

  12. Tseu F, Morley C, Mackintosh A. Xamoterol, an oral agent for the treatment of sinoatrial disease?Br Heart J 1985; 53:88.

    Google Scholar 

  13. Viersma J, Van Den Berg M, Van Gilst, et al. Intrinsic sympathomimetic activity (ISA) of pindolol in patients with sinus node dysfunction.Eur Heart J 1986;7:42.

    PubMed  Google Scholar 

  14. de Marneffe M, Haardt R, Melot C, et al. Beta-blocking agent with high intrinsic sympathomimetic activity for treatment of sick sinus syndrome (abstract).Pace 1987; 10:667.

    Google Scholar 

  15. Mandel W, Hayakawa H, Danzig R et al. Evaluation of sino-atrial node function in man by overdrive suppression.Circulation 1971;44:59.

    PubMed  Google Scholar 

  16. Reiffel J, Gang E, Bigger J. Sinus node recovery time related to pace cycle length in normals and patients with sinoatrial dysfunction.Am Heart J. 1982;104:746.

    PubMed  Google Scholar 

  17. Strauss H Saroff A, Bigger J, et al. Premature atrial stimulation as a key to the understanding of sinoatrial conduction in man.Circulation 1973;47:86.

    PubMed  Google Scholar 

  18. Ikäheimo M, Takkunen J. The effects of beta1-adrenoceptor partial agonist ICI 118.587 on left ventricular function in patients with coronary heart disease.Int J Cardiol 1984; 5:339.

    PubMed  Google Scholar 

  19. Jennings G, Bobik A, Oddie C, et al. Cardioselectivity, kinetics, hemodynamics and metabolic effects of xamoterol.Clin Pharmacol Ther 1984;35:594.

    PubMed  Google Scholar 

  20. Jordan J, Yamaguchi I, Mandel W. Studies on the mechanism of sinus node dysfunction in the sick sinus syndrome.Circulation 1978;57:217.

    PubMed  Google Scholar 

  21. Kang, P, Gomes J, El-Sherif N. Differential effects of functional autonomic blockade on the variables of sinus nodal automaticity in sick sinus syndrome.Am J Cardiol 1982; 49:273.

    PubMed  Google Scholar 

  22. de Marneffe M, Waterschoot P, melot C, et al. Electrophysiology of the normal sinus node.J Electrophysiol 1988; 2:155.

    Google Scholar 

  23. Engel T, Leddy C, Del Gonzalez A, et al. Electrophysiologic effects of hydralazine on sinoatrial function in patients with sick sinus node syndrome.Am J Cardiol 1978;41:763.

    PubMed  Google Scholar 

  24. Weiss A, Rod J, Gotsman M, et al. Hydralazine in the management of symptomatic sinus bradycardia.Eur J Cardiol 1981;12:261.

    PubMed  Google Scholar 

  25. Lewis S, Rozenman Y, Merdler A, et al.., Chronotropic effect of hydralazine and its mechanism in symptomatic sinus bradycardia.Am J Cardiol 1987;59:93.

    PubMed  Google Scholar 

  26. Benditt D, Benson W, Kreitt J et al. Electrophysiologic effects of theophylline in young patients with recurrent symptomatic bradyarrhythmias.Am J Cardiol 1983;52:1223.

    PubMed  Google Scholar 

  27. Dhingra R, Amat-Y-Leon F, Wyndham C, et al. Electrophysiologic effects of atropine on sinus node and atrium in patients with sinus nodal dysfunction.Am J Cardiol 1976;38:848.

    PubMed  Google Scholar 

  28. Mertens H, Mannebach M, Trieb G, et al. Electrophysiologic and clinical findings with ipratrodium bromide.Therapie Woche 1984;50:19.

    Google Scholar 

  29. Dhingra R, Sinus node dysfunction.Pace 1983;6:1062.

    PubMed  Google Scholar 

  30. Rizzon P, Di Biase M, Chiddo A, et al. Electrophysiological properties of intravenous metoprolol in man.Br Heart J 1978;40:650.

    PubMed  Google Scholar 

  31. Nuttall A, Snow H. The cardiovascular effects of ICI 118, 587: A β1-adrenoceptor partial agonist.Br J Pharmac 1982;77:381.

    Google Scholar 

  32. Detry, J, Decoster P, Brasseur L. Hemodynamic effects of corwin (ICI 118,587). A new cardioselective betaadrenoceptor partial agonist.Eur Heart J 1983;4:584.

    PubMed  Google Scholar 

  33. Rousseau M, Pouleur H, Vincent M. Effects of a cardioselective beta partial agonist (corwin) on left ventricular function and myocardial metabolism in patients with previous myocardial infarction.Am J Cardiol 1983;51:1267.

    PubMed  Google Scholar 

  34. Bowes R, Gautam P, Graham D, et al. The electrophysiological effects of intravenous xamoterol in humans.J Electrophysiol 1987;1:266.

    Google Scholar 

  35. Narula O, Samet P, Javier R. Significance of the sinus node recovery time.Circulation 1972;45:140.

    PubMed  Google Scholar 

  36. Pop T, Fleischmann D. Measurement of sinus node recovery time after atrial pacing. In: Bonke F, ed.The sinus node. Dordrecht: Martinus Nijhoff, 1978:23.

    Google Scholar 

  37. Narula O, Shantha N, Narula L, et al. Clinical and electrophysiological evaluation of sinus node function. In: Narula O, ed.Cardiac arrhythmias. Baltimore: Williams and Wilkins, 1979:176.

    Google Scholar 

  38. Capucci A, Prabetti L, Melandri G, et al. Electrophysiological properties of prenalterol.Int J Cardiol 1983;2:391.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiology Department, Saint-Pierre University Hospital, Rue Haute, 322, B-1000, Brussels, Belgium

    M. de Marneffe MD, P. Waterschoot, A. Bernard, P. Dubois, F. Boujelben, I. Liebens & M. Englert

Authors
  1. M. de Marneffe MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Waterschoot
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Bernard
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. Dubois
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. F. Boujelben
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. I. Liebens
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. Englert
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

de Marneffe, M., Waterschoot, P., Bernard, A. et al. Electrophysiologic effects of intravenous xamoterol in patients with sinus node dysfunction. Cardiovasc Drug Ther 4, 523–527 (1990). https://doi.org/10.1007/BF01857764

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01857764

Key Words

Search

Navigation